Food News and Research

RSS

Lung-MAP, ALCHEMIST clinical trials offer innovative study designs for lung cancer patients

The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. These clinical trials are the direct result of a National Cancer Institute sponsored workshop chaired by Drs. Fred R. Hirsch, Shakun Malik and Claudio Dansky- Ullman, that brought together the NCI Thoracic Malignancies Steering Committee, the US Food and Drug Administration, academicians, clinicians as well as industry and government stakeholders to discuss issues and challenges related to clinical trial design and biomarkers for lung cancer targeted-therapies.

29 Sep 2014

Emergency or disaster preparedness begins at home

Preparedness for an emergency or disaster begins at home. That's the message officials are trying to convey during September, which is National Preparedness Month.

29 Sep 2014

Study demonstrates longer-term benefits of Lung Flute for COPD patients

Patients with chronic obstructive pulmonary disease (COPD) report improved symptoms and health status when they use a hand-held respiratory device called the Lung Flute-, according to a new study by the University at Buffalo. Usually caused by smoking, COPD, which includes chronic bronchitis and emphysema, is the third leading cause of death in the U.S.

29 Sep 2014

Canadian government committed to prevent, detect, and respond to infectious disease outbreaks

The Honourable Rona Ambrose, Minister of Health, committed to continued efforts to strengthen global health security at the Global Health Security Agenda (GHSA) meeting in Washington, DC.

27 Sep 2014

Bioniche Life Sciences announces year-end results for fiscal 2014, provides corporate update

Bioniche Life Sciences Inc. today announced financial results for its fiscal year ended June 30, 2014.

27 Sep 2014

Agrisoma Biosciences closes Series A financing round

Agrisoma Biosciences Inc. an agriculture technology company, today announced the first closing of its Series A financing round, expected to total $8 million through 2014.

27 Sep 2014

Consumers for Dental Choice praises EPA's dental mercury rule

Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.

27 Sep 2014

UCLA research may lead to novel treatment for PH1

Research by UCLA biochemists may lead to a new treatment - or even a cure - for PH1, a rare and potentially deadly genetic kidney disease that afflicts children. Their findings also may provide important insights into treatments for Parkinson's disease, Alzheimer's disease and other degenerative diseases.

27 Sep 2014

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

27 Sep 2014

Gastric bypass surgery provides better results than gastric banding

Gastric bypass surgery has better outcomes than gastric banding for long-term weight loss, controlling type 2 diabetes and high blood pressure, and lowering cholesterol levels, according to a new review by UT Southwestern Medical Center surgeons of nearly 30 long-term studies comparing the two types of bariatric procedures.

26 Sep 2014

AcelRx plans for resubmission of Zalviso NDA

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today provided an update on the plans for the resubmission of the Company's New Drug Application (NDA) for Zalviso (sufentanil sublingual tablet system).

26 Sep 2014

Access to potentially life-extending cancer drugs varies worldwide

Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show at the ESMO 2014 Congress in Madrid, Spain.

26 Sep 2014

CorMedix submits IND application to FDA for Neutrolin

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.

25 Sep 2014

Genetic factors influence consumption of alcoholic beverages

How people perceive and taste alcohol depends on genetic factors, and that influences whether they "like" and consume alcoholic beverages, according to researchers in Penn State's College of Agricultural Sciences.

25 Sep 2014

Viewpoints: A 'success story' in McAllen, Texas; 'uniquely high prices' in health care

It may have been the most influential magazine article of the past decade. In June of 2009, the doctor and writer Atul Gawande published a piece in The New Yorker called "The Cost Conundrum," which examined why the small border city of McAllen, Tex., was the most expensive place for health care in the United States. ... Five years later, the situation has changed. Where McAllen once illustrated the problem of American health care, the city is now showing us how the problem can be solved, largely because of the Affordable Care Act that Mr. Obama signed into law in 2010 (Bob Kocher and Farzad Mostashari, 9/23).

25 Sep 2014

Anti-addiction activists press for FDA chief to step down

More than a dozen organizations are asking that Dr. Margaret Hamburg, who has headed the Food and Drug Administration since 2009, be replaced because under her leadership they say the agency's policies have contributed to prescription painkiller abuse.

25 Sep 2014

RDT receives FDA clearance for Tempus Pro advanced medical monitor

RDT is pleased to announce that, following CE and other market approvals, it has received 510k clearance by the US Food and Drug Administration for the addition to the Tempus Pro medical monitor of: 12 Lead ECG recording interpretation, real-time arrhythmia detection, ST and QT monitoring and alarming (unique to a fully-featured pre-hospital transport monitor) an additional two channels of invasive blood pressure (four in total), Masimo rainbow SET co-oximetry, video laryngoscope and ultrasound.

24 Sep 2014

Eurest introduces new food and nutrition concept to promote worksite health, sustainability

National Institute of Health's contracted food service partner, Eurest, proudly introduced a new pioneering food and nutrition concept called 'Balance Kitchen' in the ACRF Cafe that is designed to foster and promote worksite health and sustainability.

24 Sep 2014

New report shows lifestyle changes, new technology make people stay healthy in old age

If we embrace lifestyle changes and new technology, we improve our prospects of staying healthy in old age, getting good care and reducing our dependence on others. This is the message of a new report summarising the conclusions from the Uppsala Health Summit in June.

24 Sep 2014

Understanding ways to treat, cure eosinophilic gastritis

Investigators at Cincinnati Children's Hospital Medical Center have published the first study to extensively characterize eosinophilic gastritis (EG).

24 Sep 2014